Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Physical Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00262249
What this trial is testing

Effect of Growth Hormone in Children With Growth Hormone Deficiency

Who this might be right for
Growth Hormone DisorderGrowth Hormone Deficiency in ChildrenGrowth Disorder+1 more
Novo Nordisk A/S 173
Not applicableUnknownNCT03374033
What this trial is testing

High Protein and High Energy Intakes and Physical Activity on Growth of Extremely Low Birth Weight Infants

Who this might be right for
Infant, Very Low Birth Weight
Università Politecnica delle Marche 200
Early research (Phase 1)Active Not RecruitingNCT03513484
What this trial is testing

Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2AFibroblast Growth Factor Basic Form MeasurementFLT3 Internal Tandem Duplication+2 more
Northwestern University 44
Testing effectiveness (Phase 2)Study completedNCT01372384
What this trial is testing

Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 6
Not applicableStudy completedNCT01162798
What this trial is testing

Preterm Infant Growth

Who this might be right for
GrowthDevelopmentInfant
Société des Produits Nestlé (SPN) 150
Early research (Phase 1)Study completedNCT00647114
What this trial is testing

Test V930/V932 in Patients With Cancers Expressing Human Epidermal Growth Factor Receptor 2 (HER-2) and/or Carcinoembryonic Antigen (CEA)(V930-003)(COMPLETED)

Who this might be right for
Cancer
Merck Sharp & Dohme LLC 41
Testing effectiveness (Phase 2)Study completedNCT02239731
What this trial is testing

Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients

Who this might be right for
Rash Due to Epidermal Growth Factor Receptor Inhibitors
Vyne Therapeutics Inc. 24
Not applicableUnknownNCT02335801
What this trial is testing

The TOSCA Registry: Hormonal and Metabolic Deficiencies in Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
Federico II University 650
Testing effectiveness (Phase 2)Study completedNCT03007992
What this trial is testing

Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Johannes Gutenberg University Mainz 9
Not applicableStudy completedNCT03246711
What this trial is testing

Can Fasting Ramadan in the Third Trimester in Pregnancy Affects the Fetal Growth.

Who this might be right for
FastingFetal Growth Retardation, Antenatal (Disorder)
Ain Shams Maternity Hospital 159
Not applicableNot Yet RecruitingNCT07669545
What this trial is testing

Risk Stratification and Treatment Decisions in Infantile Hemangioma With Minimal or Arrested Growth

Who this might be right for
Infantile Hemangioma (IH)
West China Hospital 150
Not applicableLooking for participantsNCT07546695
What this trial is testing

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study

Who this might be right for
Breast Cancer
University Hospital, Basel, Switzerland 600
Testing effectiveness (Phase 2)Study completedNCT00116129
What this trial is testing

Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia

Who this might be right for
Fibromyalgia
Bennett, Robert, M.D. 64
Not applicableStudy completedNCT01446302
What this trial is testing

Metabolic and Inflammatory Responses to Hemodialysis and the Effect of a Meal

Who this might be right for
Kidney Failure, Chronic
University of Aarhus 24
Testing effectiveness (Phase 2)Study completedNCT01763307
What this trial is testing

Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI

Who this might be right for
Rash Due to Epidermal Growth Factor Receptor Inhibitors
Hadassah Medical Organization 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05077800
What this trial is testing

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Adenocarcinoma Metastatic
Colin D. Weekes, M.D., PhD 70
Post-approval studies (Phase 4)Study completedNCT01877512
What this trial is testing

GH and Cardiovascular Risk Factors

Who this might be right for
Growth Hormone DeficiencyCardiovascular DiseasesMetabolic Syndrome+2 more
Amsterdam UMC, location VUmc 32
Post-approval studies (Phase 4)Study completedNCT00134745
What this trial is testing

Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome

Who this might be right for
Turner Syndrome
Line Cleemann 43
Testing effectiveness (Phase 2)Study completedNCT00719212
What this trial is testing

Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Translational Research in Oncology 61
Testing effectiveness (Phase 2)Study completedNCT01736410
What this trial is testing

Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Who this might be right for
HER 2 Positive Advanced Gastric Cancer
National Cancer Centre, Singapore 30
Next Page